We are live on ! Find out more
MSAC

Medicus Sciences Acquisition Corp. Class A Ordinary Share

Delisted

MSAC was delisted on the 17th of February, 2023.

49 hedge funds and large institutions have $110M invested in Medicus Sciences Acquisition Corp. Class A Ordinary Share in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

5% more capital invested

Capital invested by funds: $105M → $110M (+$5.09M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

8% less funds holding

Funds holding: 5349 (-4)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
49
Holders Change
-4
Holders Change %
-7.55%
% of All Funds
0.79%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
9
Reduced
8
Closed
7
Calls
$10K
Puts
Net Calls
+$10K
Net Calls Change
+$7K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Sio Capital Management
New York
$23.4M
GCL
2
Glazer Capital LLC
New York
$9.09M -$74.9K -7,511 -0.8%
SCM
3
Saba Capital Management
New York
$8.24M
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$7.96M
FTCM
5
First Trust Capital Management
Illinois
$6.85M +$2.8M +280,438 +70%
APM
6
Avidity Partners Management
Texas
$5.24M
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$4.63M +$1.39M +139,076 +43%
WCMNY
8
Westchester Capital Management (New York)
New York
$4.4M +$2M +200,000 +84%
CSS
9
Cubist Systematic Strategies
Connecticut
$4.1M +$1.01M +101,676 +33%
MSU
10
Mizuho Securities USA
New York
$3.2M +$589K +59,031 +22%
WAM
11
Weiss Asset Management
Massachusetts
$3.02M -$2M -200,000 -40%
KCM
12
Kingdon Capital Management
New York
$3.02M
RI
13
RTW Investments
New York
$3.02M
Bank of America
14
Bank of America
North Carolina
$2.62M
Hudson Bay Capital Management
15
Hudson Bay Capital Management
Connecticut
$2.52M
KIM
16
Karpus Investment Management
New York
$2.3M -$71.1K -7,125 -3%
PC
17
Periscope Capital
Ontario, Canada
$1.6M +$998K +100,000 +171%
SIA
18
Schechter Investment Advisors
Michigan
$1.36M -$108K -10,810 -7%
FTCM
19
Fir Tree Capital Management
New York
$1.22M -$64.6K -6,470 -5%
KKRC
20
Kohlberg Kravis Roberts & Co
New York
$1.14M
JAM
21
JW Asset Management
Florida
$1.01M
CF
22
Cantor Fitzgerald
New York
$993K
CCA
23
Cruiser Capital Advisors
Connecticut
$930K
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$899K +$294K +29,446 +49%
Goldman Sachs
25
Goldman Sachs
New York
$859K

MSAC Hedge Fund Activity: Q4 2022 in Review

49 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) for Q4 2022, worth a combined $110M — up 4.8% from $105M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of MSAC and 3 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 9 added.

The largest buyer was First Trust Capital Management, adding an estimated $2.8M. The largest seller was Weiss Asset Management, cutting an estimated $2M.

  • 49 institutional investors held Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $110M of Medicus Sciences Acquisition Corp. Class A Ordinary Share stock for Q4 2022, up 4.8% quarter-over-quarter.
  • 3 funds opened new Medicus Sciences Acquisition Corp. Class A Ordinary Share positions in Q4 2022 and 7 closed out, a net change of -4 holders.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share buyer in Q4 2022 was First Trust Capital Management, an estimated $2.8M added.
  • The largest Medicus Sciences Acquisition Corp. Class A Ordinary Share seller in Q4 2022 was Weiss Asset Management, an estimated $2M sold.

Based on aggregated 13F filings for Q4 2022.